Henry Johnson Email

VP, Chemistry . Tempest Therapeutics

Current Roles

Employees:
33
Revenue:
$5.1M
About
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. Tempest has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct immune response pathways relevant to mounting an effective anti-tumor response. The molecules were developed by Inception Sciences, a Versant Ventures affiliated drug discovery engine. Tempest has assembled a highly experienced team of small molecule and immuno-oncology drug developers to advance these programs to the clinic across diverse cancers representing significant unmet medical need. Tempest is backed by a syndicate of leading US and China based venture capital firms.
Tempest Therapeutics Address
7000 Shoreline Court
San Francisco, CA
United States
Tempest Therapeutics Email

Past Companies

Tempest TherapeuticsVice President, Chemistry

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.